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Abstract.  Riboflavin carrier protein which is obligatorily involved in yolk deposition of the
vitamin in the chicken egg, is a unique glycophosphoprotein present in both the yolk and
white compartments. The yolk and egg white proteins are products of a single estrogen-
inducible gene expressed in the liver and the oviduct respectively of egg laying birds. Despite
the fact that the carbohydrate composition of the yolk and white riboflavin carrier proteins
differ presumably due to differential post-translational modification, the proteins are
immunologically similar and have identical amino acid sequence (including a cluster of 8
phosphoser residues towards the C-terminus) except at the carboxy terminus where the yolk
riboflavin carrier protein lacks 13 amino acids as a consequence of proteolytic cleavage
during uptake by oocytes. The protein is highly conserved throughout evolution all the way
to humans in terms of gross molecular characteristics such as molecular weight and
isoelectric point, and in immunological properties, preferential affinity for free riboflavin
and estrogen inducibility at the biosynthetic locus viz., liver. Obligatory involvement of the
mammalian riboflavin carrier protein in transplacental flavin transport to subserve fetal
vitamin nutrition during gestation is revealed by experiments using pregnant rodent or sub-
human primate models wherein immunoneutralisation of endogenous maternal riboflavin
carrier protein results in fetal wastage followed by pregnancy termination due to selective
yet drastic curtailment of vitamin efflux into the fetoplacental unit. Using monoclonal
antibodies to chicken riboflavin carrier protein, it could be shown that all the major
epitopes of the avian riboflavin carrier protein are highly conserved throughout evolution
although the relative affinities of some of the epitopes for different monoclonal antibodies
have undergone progressive changes during evolution. Using these monoclonal antibodies,
an attempt is being made to map the different epitopes on the riboflavin carrier protein
molecule with a view to delineate the immunodominant regions of the vitamin carrier to
understand its structure-immunogenicity relationship. 
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Introduction 
 
Vitamin carrier proteins capable of high-affinity interaction with their respective
vitamins are present throughout the animal kingdom and play a vital role in the life
processes of the vertebrates. A great deal of information has been accumulated
during the last few years regarding the biological significance of these specific
proteins, whose functions include storage and transport of vitamins and prevention
of rapid losses of these vital nutrients due to excretion and/or metabolic degradation.
Vitamins are known to remain biologically inert as long as they are associated with
their carrier proteins and can be activated only upon dissociation. The specific
interaction of vitamins with their respective carriers is through non-covalent forces,
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thereby permitting a reversible dissociation of the unmodified ligands from the 
carriers under appropriate physiological conditions. These aspects together with 
their ubiquitous distribution make them attractive candidates for the study of their 
biochemical and physiological roles as well as their evolutionary conservation. 
 
Riboflavin carrier proteins 
 
Specific carrier proteins have been identified in oviparous species for riboflavin 
(Rhodes et al., 1959; Ostrowski et al., 1962), thiamin (Muniyappa and Adiga, 1979, 
1981), biotin (Eakin et al., 1940; White et al., 1976), vitamin B12 (Sonneborn and 
Hensen, 1970), retinol (Kanai et al., 1968), vitamin D (Fraser and Emtage, 1976) and 
folic acid (Krishnamurthy, 1984). It is appropriate to mention that some of these 
vitamin carriers (for retinol, vitamin D and folic acid) are constitutive to the species, 
and their hepatic elaboration may be significantly enhanced by appropriate 
endocrine stimuli to meet the accelerated demand during egg laying. In contrast, 
others such as those specific for riboflavin, thiamin and biotin are induced de novo 
solely as a reproductive strategem to facilitate vitamin deposition in the developing 
oocyte (Murthy and Adiga, 1978a; Malathy and Adiga, 1985). These then become 
detectable both in the eggs and in the maternal circulation. All these vitamins are 
present at 5–10-fold higher concentrations in the egg than in the maternal circulation; 
the interaction with carrier proteins apparently facilitates concentration of the 
vitamins for deposition in the egg (Coates, 1971). These carrier proteins bind the 
vitamin with a higher affinity than the respective co-enzyme derivatives and this may 
be a mechanism by which the developing oocyte can sequester the vitamins for its 
own use in the most appropriate form. 
Among the various vitamin carriers hitherto studied from different avian species, 
chicken riboflavin carrier protein (RCP) is the best characterised, apparently because 
relatively simple procedures are involved in its isolation in good yields from egg 
white. Other attractive features associated with this vitamin carrier are: (i) its 
presence, unlike other major egg proteins, in both egg yolk and white, which could 
mean dual loci of biosynthesis viz., the liver and the oviduct respectively of egg laying 
hens, (ii) its inducibility de novo presumably by sex steroids and hence its potential 
as a model system for studies of steroid hormone induced gene expression and (iii) its 
reversible, high-affinity interaction with flavin which makes it an attractive flavor- 
protein system with which to understand the structural features involved in ligand- 
protein interaction. Investigations in our laboratory and elsewhere have led to an 
understanding of its structure and function in well-defined terms and an overview of 
the available information is presented below. 
RCPs have been isolated from both compartments of the egg (Ostrowski et al., 
1962; Murthy and Adiga, 1977) as well as from the serum of laying hens (Murthy and 
Adiga, 1978b) and the proteins are identical immunologically and biochemically in 
terms of their affinity and preference for riboflavin. Egg white RCP has recently been 
crystallised (Zanotti et al., 1984). 
 
Biochemical aspects 
 
Chicken RCP is a phosphoglycoprotein with molecular weight (M r) 37,000 and
exhibits preferential affinity for riboflavin in the Ka range 106–108 M-1 (Rhodes et 
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al., 1959). Both egg white and yolk RCP were earlier postulated to consist of two 
non-identical subunits (M r 24,000 and 8,000) joined by two interchain disulphide
bridges (Philips, 1969). However, this has not been confirmed either in our 
laboratory or elsewhere (Murthy and Adiga, 1977; Becvar and Palmer, 1982; Kozik, 
1982). Analysis of carbohydrate composition of egg white RCP has revealed that the 
protein contains 10% hexosamine and 4% neutral sugars with a single sialic acid 
residue at the terminus of a highly branched oligosaccharide chain (Philips, 1969). 
Egg yolk RCP contains both hexose and hexosamine as well as multiple sialic acid 
residues (Ostrowski et al., 1968). The sequences of these oligosaccharides are yet to 
be elucidated. 
Analysis of the amino acid composition of RCP shows the presence of all the 
common amino acids (Norioka et al., 1985); the protein is particularly rich in 
glutamic acid, serine and aromatic amino acids. The amino acid sequences of RCP 
(figure 1) from egg white and serum have been compared (Norioka et al., 1985) and 
found to be identical; the yolk RCP also has identical sequence except at the 
carboxyl terminus where it lacks 13 amino acids. It is therefore reasonable to 
 
 
Figure 1 Amino acid sequence of chicken egg white riboflavin carrier protein (from 
Hamazume et al., 1983). 
 
<Glu, Pyroglutamyl residue; CHO, carbohydrate chain; Ser phosphoserine,: cleavage
site for yolk RCP. P
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assume that during incorporation of circulatory RCP into the oocyte or yolk fluid, 
the C-terminal end is cleaved in a specific manner (Deeley et al., 1975), somewhat like 
the processing by proteolysis of vitellogenin to form lipovitellin and phosphovitin 
(Bergink et al., 1974). Thus RCP is the second example among yolk proteins that is 
enzymatically modified during incorporation into the yolk. In other respects, yolk 
RCP has the same characteristics as egg white RCP, and these include the N- 
terminal pyroglutamic acid, polymorphism in the amino acid sequence 
(lysine/asparagine at the 14th residue from the N-terminus) and carbohydrate chains 
attached to Asn-36 and Asn-147 residues. Phosphate groups are also bound to the 
same serine residues which occur in a cluster between positions 187 and 197 in both 
yolk and white RCPs. All these observations confirm the earlier hypothesis based on 
genetic analysis that yolk, plasma and white RCPs are derived from the same 
structural gene (Norioka et al., 1985). 
An intriguing aspect of this phosphoprotein is that all the phosphate groups are 
localised as phosphoserine moieties in a restricted, highly anionic region of the 
peptide chain (Norioka et al., 1985); thus within a 21 amino acid segment are found 8 
phosphoserine residues and 5 glutamate residues (figure 1). This peptide can be 
isolated by trypsin digestion of reduced and carboxymethylated RCP (Miller et al., 
1984) and has lysine at its C-terminal and histidine at the N-terminal ends. 
Sandwiched between these two basic amino acids is a sequence of 21 amino acids 
among which 14 carry one or two negative charges at physiological pH. In view of 
the high degree of charge repulsion, it is assumed that this phosphopeptide is rigid, 
with little or no ordered secondary structure. A highly conspicuous feature of this 
phosphopeptide is the palindromic sequence around Met-194. This residue is 
sandwiched between 6 phosphoserine and 4 glutamic acid residues in a defined 
sequence. The biological significance of this rather unique amino acid sequence is 
currently unknown. 
The carbohydrate composition of yolk RCP is identical to that of plasma RCP, 
but both differ from that of egg white RCP showing that the post-translational 
attachment of carbohydrate chains of RCP differs in the liver and oviduct. However, 
it is intriguing that the phosphorylation sites of egg yolk RCP are similar to those of 
egg white RCP, indicating that protein kinases with similar specificities participate in 
the phosphorylation of the protein in the liver and oviduct (Norioka et al., 1985). 
 
Riboflavin binding characteristics of chicken RCP 
 
Every region of RCP has been investigated for flavin binding, receptor recognition 
as well as antigenicity. Extensive work has been carried out on the flavin binding 
characteristics of the protein in an attempt to understand the sites of flavin-protein 
interactions apparently as a model for flavin co-enzyme-enzyme interaction. The 
apoprotein binds to a variety of flavin analogues in a 1:1 stoichiometry and shows a 
preferential affinity for riboflavin (Nishikimi and Kyogoku, 1973). The fluorescence 
of flavin is completely quenched on binding to egg white apo-RCP while 80% of the 
protein fluorescence is quenched on binding to riboflavin and 3-methyl riboflavin 
and 77% on binding to lumiflavin (Nishikimi and Kyogoku, 1973). Nuclear magnetic 
resonance data indicate that the chemical shifts of the carbon and nitrogen atoms of 
riboflavin hardly differ on binding to either egg white or yolk RCP indicating that 
the binding site for the oxidised isoalloxazine ring are similar in the two isoproteins 
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(Nishikimi and Kyogoku, 1973). However, thermodynamic analysis indicates that 
the cavity in which riboflavin sits in the protein is relatively smaller in yolk RCP 
than in egg white RCP (Nishikimi and Kyogoku, 1973; Matsui et al., 1982a). 
Moreover, N-3 of riboflavin is exposed to the solvent while N-10 and ribityl side 
chain are strongly involved in the interaction with the protein by formation of 
hydrogen bonds (Matsui et al., 1982b; Moonen et al., 1984). Studies using model 
compounds with different modifications of the flavin molecule reveal that the 
dimethyl benzenoid part of the ring is the predominant portion involved in inter- 
action with the apoprotein and gets buried to a large extent in the protein (Choi and 
McCormick, 1980). 
The flavin binding site in the protein has been studied by chemical modification of 
the protein. From the data obtained hitherto, it appears that tryptophan residues are 
essential for the binding of riboflavin (Murthy et al., 1976; Blankenhorn, 1978). 
Modification of 5 tryptophans completely abolished the flavin binding ability of yolk 
RCP (Miller et al., 1981a) and it has been proposed earlier that 1–2 tryptophans are 
essential for riboflavin binding in egg white RCP (Murthy et al., 1976). More recent 
studies have however revealed that one of these tryptophan residues is critically 
involved in the binding of flavin and this tryptophan is not protected by bound flavin 
against chemical modification. Tyrosine is not critically involved in flavin binding 
because extensive iodination or nitration does not alter the flavin binding capacity 
(Farrell et al., 1969). However, a further study has established that one tyrosine is 
apparently located at the binding site since it is protected against chemical 
modification by bound flavin (Blankenhorn, 1978). 
Earlier work (Murthy, 1977) has indicated that at a low pH, the protein undergoes 
self-aggregation leading to a reduced affinity for the vitamin. In fact, there is nearly 
100-fold reduction in riboflavin binding capacity on lowering the pH from 7·4–4. The 
presence of sodium dodecyl sulphate (SDS) also reduces the binding. However, 
interaction of the protein with polyclonal antibody or concanavalin-A does not seem 
to change its affinity for riboflavin, suggesting that the riboflavin binding site is 
distinct from antigenic sites (Murthy, 1977). 
 
Receptor recognition sites on RCP 
 
The function of RCP, as mentioned earlier, is confined to the deposition of the 
vitamin in the developing oocyte. It is also believed that RCP, mostly present in 
apoprotein form in egg white, may have a bacteriostatic role in sequestering the free 
vitamin released into the albumen during embryonic development (Board and Fuller, 
1974). On the other hand, RCP present in the yolk is involved essentially in meeting 
the nutritional requirements of the growing embryo. Yolk RCP is deposited into the 
yolk from the blood, with the vitamin firmly bound to it; direct evidence for this 
stems from experiments using mutant hens afflicted with the hereditary syndrome 
avian riboflavinuria (Maw, 1954). When RCP isolated from the eggs of normal hens 
was injected into laying hens homozygous for the avian riboflavinuria trait, and the 
eggs examined for evidence of transfer of RCP by immunoprecipitation, the protein 
was detected at low levels in the egg yolk at 2 days following injection, but none was 
found in the egg white (Hammer et al., 1971). This shows clearly that the blood 
protein is directly incorporated into the yolk. Furthermore, removal of sialic acid 
reduced the transport of RCP to yolk by 88% (Miller et al., 1981a), while oxidation 
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of galactose and removal of N-acetylglucosamine and galactose also led to 
diminished transport of the protein into the yolk (Miller et al., 1981b) despite the fact 
that the protein still retained riboflavin binding activity. A comparison of the 
carbohydrate composition of yolk and circulatory RCPs indicates removal, during 
ovarian uptake, of one sialic acid, one fucose, two galactose, and 3 N- 
acetylglucosamine residues from the precursor serum RCP. However, it may be 
pointed out, despite the obvious implication that the carbohydrate (especially the 
sialic acid) residues are involved in uptake by the oocyte, that no direct evidence for 
binding of RCP to the ovarian follicular membrane has been demonstrated so far 
(Miller et al., 1982a). 
Another region of RCP which has been implicated in oocyte membrane 
recognition is the phosphopeptide moiety; dephosphorylation of egg white RCP or 
yolk RCP has no effect on the binding of riboflavin by the protein, but oocyte 
uptake of the dephosphorylated protein is greatly reduced (Miller et al., 1982b). 
Removal of a single phosphate residue from yolk RCP decreases follicular uptake by 
60% and this cannot be restored by the addition of anionic groups such as by 
succinylation (Miller et al., 1982b). The phosphopeptide portion appears to function 
autonomously of the rest of the protein and could be involved in recognition of the 
putative receptor on the oocyte membrane, either through direct interaction or by 
directing the protein in such a way as to facilitate subsequent interaction with the 
receptor in a potential gradient (Miller et al., 1984). 
Interestingly, succinylation of the native protein also decreases its uptake by the 
oocytes (Miller et al., 1981b) indicating that uptake also involves other segments of 
the peptide chain. Hence, uptake of RCP by oocytes may be a complex sequence of 
protein-receptor interaction involving phosphate, sialic acid and lysine residues and 
elucidation of the mechanism awaits further research. 
 
Mammalian RCPs 
 
In contrast to the extensive knowledge available on chicken RCP, the information 
on mammalian RCPs is limited to a few cases. The first demonstration of RCP from 
a mammalian source was reported from our laboratory (Adiga and Muniyappa, 
1978; Nutrition Reviews, 1979). Using a sensitive radioimmunoassay (RIA) involving 
iodinated chicken RCP and antiserum to chicken RCP, a protein cross-reacting with 
chicken RCP could be detected in pregnant rat serum (Muniyappa, 1980). The 
protein has been purified by lumiflavin-affinity chromatography, though its Mr was 
ambiguous. More recent data from our laboratory however reveal that the rodent 
RCP purified by fast protein liquid chromatography has a molecular size 
comparable to that of chicken RCP (Karande, A. A. and Adiga, P. R. unpublished 
results). Evidence for the functional role of rat RCP has also been obtained. 
Administration of antibodies to chicken RCP to pregnant rats leads to pregnancy 
termination (Muniyappa and Adiga, 1980) consequent to a decrease in uptake of 
riboflavin by the developing embryo (Murty and Adiga, 1981). Further studies on the 
mechanism of fetal wastage has revealed (Krishnamurthy et al., 1984) that the drastic 
curtailment of vitamin supply to the embryo leads to profound changes in the 
pattern of co-enzyme levels particularly that of FAD as a consequence of inhibition 
of FAD synthesis coupled with high activity of the catabolic enzyme present in the 
embryonic tissue (Surolia et al., 1985). 
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Following active immunisation of normal female rats with chicken RCP the 
consequent chronic in vivo immunoneutralisation of maternal RCP leads to 
termination of pregnancy around days 8–10 of gestation. It has been proposed that 
rat RCP may not be involved in the fertilization/implantation process per se but is 
definitely required for providing adequate riboflavin to the developing fetus (Murty 
and Adiga, 1982a). Pregnancy continues to term with the delivery of normal pups 
when circulating antibody concentrations are allowed to wane with time in actively 
immunized rats (Murty and Adiga, 1982a), showing the reversibility of the immuno- 
neutralisation process. 
Another claim for the occurrence of RCP in a mammal was made by Merrill et al. 
(1979), who purified RCPs from bovine plasma and adduced evidence for a 
Pregnancy-specific riboflavin binding protein. These proteins have been isolated by 
affinity chromatography using N3-carboxymethyl riboflavin coupled to AH- 
Sepharose. At least 3 major protein bands could be observed migrating in regions 
ascribed to the β- and γ-globulins of plasma following cellulose acetate electro- 
phoresis. The Mr of one of these proteins was 150,000 as assessed by gel filtration, 
but the interesting observation was that a small amount of another riboflavin 
binding protein of Mr 37,000 was also present. All 3 proteins bound [14C]-riboflavin 
avidly, with high affinity (kd= 10-6 mol/litre). The presumed pregnancy-specific, low 
Mr protein from bovine serum was purified to apparent homogeneity and appeared 
to have an even higher affinity for riboflavin. No further analysis of these proteins 
has been forthcoming, but it is claimed that a certain protein binding riboflavin with 
high affinity is associated with pregnancy in higher mammals with a function 
analogous to that of serum RCP in laying hens. 
Earlier studies on RCPs in higher mammals were confined to their detection and 
partial characterisation in human sera. Merrill et al. (1979) have reported that 
besides albumin, which is known to associate with riboflavin with low affinity (Jusko 
and Levy, 1975), a certain fraction of immunoglobulin G (IgG) also binds riboflavin 
with a reasonably high affinity (4 µΜ) (Merrill et al., 1981). This fraction (about 1% 
of total IgG) could be isolated by affinity chromatography and is non-specific in the 
sense that it is present in the sera of male and female non-pregnant and pregnant 
individuals. However, because of the relatively higher concentrations of albumin in 
the serum it has been suggested that only 5-6% of protein-bound riboflavin in 
normal human plasma is associated with this IgG fraction (Merrill et al., 1981). 
It seems unlikely that riboflavin is the antigen inducing these immunoglobulins 
and it is conceivable that ligand binding is accomplished on a site on these proteins 
which accomodates the flavin and/or ribityl side-chains. Eisen et al. (1970) have 
observed that a monoclonal immunoglobulin A produced by mouse plasmacytoma 
MOPC-315 binds riboflavin (Kd 36 µΜ) and other hydrophobic compounds 
moderately tightly. A much tighter binding of riboflavin has been reported by 
Farhangi and Osserman (1976) for a monoclonal IgG (IgGgar) produced by a patient 
with multiple myeloma. This human monoclonal IgG 2 (λ) is separable into two 
similar fractions by ion-exchange chromatography; one of these fractions is nearly 
saturated with the ligand with an average of about 2 equivalents of riboflavin/mol, 
while the second, slightly more acidic, fraction has a small amount of riboflavin 
associated with it (about 0·2 equivalent flavin/mol) (Farhangi and Osserman, 1976). 
The vacant site on native IgGgar reversibly binds up to a total of 2 equivalents of 
riboflavin per mol of protein. Sites already occupied by riboflavin bind the flavin 
irreversibly and the vitamin is dissociated only on denaturation by urea (Chang et 
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al., 1981a, b). Using a variety of flavin analogues, the regions on the riboflavin 
molecule which associate with the binding site have been identified (Pologe et al., 
1982). The pyrimidine edge of the isoalloxazine does not interact with the combining 
site, particularly around N-3. The ribityl side chain and dimethyl benzene edge of the 
flavin ring are critical for binding and are probably not exposed (Pologe et al., 1982). 
A comparison with flavoproteins show that IgGgar binds riboflavin in a rather novel 
way. The isoalloxazine ring interacts in a way similar to that in FMN binding 
proteins, but unlike the situation in flavoproteins, the ribityl side chain is not 
essential for binding. Further investigations are required to shed light on the 
essential features of this flavin binding site and the way in which such a site is 
manifest as an integral part of a human monoclonal immunoglobulin. 
There has been a recent claim that another protein fraction which binds riboflavin 
with high affinity can be obtained from human fetal cord blood and is present in 
relatively smaller amounts (25µg/15ml blood) (Merrill et al., 1981). Further 
information regarding molecular size or other characteristics is not available at 
present, but it has been proposed that human blood like blood of other mammals, 
contains proteins which may serve an ancilliary role to albumin in pregnancy, 
analogous to the role of RCP in avian eggs. 
We have recently isolated and characterised RCPs from pregnant bonnet monkey 
and human sera (Visweswariah and Adiga, 1987a, b). A heterologous RIA using 
[125I]-labelled chicken RCP and antiserum to chicken RCP was employed to show 
that sera from pregnant bonnet monkeys and humans (Visweswariah and Adiga, 
1987a, b) are able to inhibit the binding of chicken RCP to specific antiserum. 
Human umbilical cord serum also contains a cross-reacting protein, in higher 
concentrations than in maternal pregnancy sera. Isolation of these proteins involves 
sophisticated protein purification techniques such as fast protein liquid chromato- 
graphy involving ion-exchange and chromatofocusing. The purified proteins 
exhibited properties with remarkable similarities to those of the chicken vitamin 
carrier. Thus, the Mr of both monkey and human RCP (from either pregnancy or 
umbilical cord sera) are similar to that of chicken RCP (37,000). All the proteins are 
acidic in nature (pI < 4) and preferentially bind riboflavin vis-a-vis FMN and FAD. 
The purified proteins bind to specific antibodies against chicken RCP which is 
indicative of extensive sequence similarity amongst the proteins. The sequence 
similarity could be confirmed by comparing the tryptic peptide maps of [125I]- 
labelled monkey RCP and chicken RCP. Thus, RCP is a protein which has been 
retained to near identity from aves to primates. This is strongly suggestive of a vital 
role for this protein in primate reproduction as well. 
 
Hormonal modulation of RCP 
 
It is now well established that the de novo synthesis of yolk proteins in the liver of 
oviparous vertebrates is clearly in response to augmented circulatory levels of 
estrogen during egg-laying; synthesis can also be induced by administration of the 
steroid (Tata and Smith, 1979). Egg white protein synthesis in the oviduct is also 
hormone-dependent (Kohler et al., 1968; Oka and Schimke, 1969; Palmiter and 
Gutman, 1972). Since RCP is present in both yolk and white of chicken eggs, we have 
investigated the details of hormonal modulation of chicken RCP synthesis in the 
liver and oviduct by administration of hormones to immature male and female 
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chicks. The induced proteins are secreted by the respective biosynthetic organs even 
in the absence of a developing oocyte in which they are normally sequestered 
(Cecchini et al., 1979) and hence plasma or oviduct tissue concentrations reflect the 
synthetic capacities of liver and oviduct, respectively. 
We developed (Murthy and Adiga 1978a) a RIA for chicken RCP to monitor the 
circulating levels of the protein following estradiol-17β administration to immature 
male chickens. After a single injection of the hormone, the plasma RCP level is 
enhanced several-fold at 6 h, reaching peak levels around 48 h and declining 
thereafter to the basal level. A 2-fold amplification of the response is observed on 
secondary stimulation with the hormone. A 4h lag phase prior to the onset of 
induction is noticed during both primary and secondary stimulations with the 
hormone. The synthesis of the protein is dependent on the dose of hormone 
administered, with the maximum effect observed with 10 mg/kg body weight. There 
is no appreciable change in the half-life of the protein on estradiol-17 β 
administration but the half-life is modulated by the thyroid status of the animal 
(Murthy and Adiga, 1978a). Progesterone is unable to affect the kinetics of estradiol- 
17β induced RCP production, but antiestrogens are potently capable of blocking the 
response. 
A detailed comparison of the induction of RCP in the liver and oviduct has been 
carried out in our laboratory (Durga Kumari, 1984). On primary stimulation of 
immature female birds with estradiol-17ß (10 daily injections), there is a rapid 
increase in oviduct weight and total RCP after an initial lag period of 2–3 days. 
Secondary stimulation with estradiol-17ß results in a rapid increase in RCP levels 
without the lag period. Progesterone treatment results only in a slight increase in 
oviduct weight; it can also activate the differentiated oviduct cell function in terms of 
RCP synthesis, but only during secondary stimulation, i. e., after primary stimulation 
with estradiol- 17β. The plasma levels of RCP in these birds reflect progressive 
increase in synthesis of RCP on primary stimulation with estradiol- 17 β and the 
characteristic memory effect with attendant amplification of the inductive response 
during secondary stimulation. However, progesterone is unable to stimulate the 
synthesis of RCP by the liver when administered as secondary inducer, unlike the 
phenomenon observed in the oviduct (Durga Kumari and Adiga, 1986). These 
observations bring into focus subtle qualitative differences in the hormonal 
regulation of the RCP gene in the two estradiol-17 β dependent avian tissues. The 
differences may be a reflection of differential modulation of tissue-dependent 
regulatory elements governing RCP gene expression in the two biosynthetic loci. 
Cell-free translation of (polyA+) RNA from both liver and oviduct has revealed 
that enhanced RCP mRNA levels account for the increased synthesis of RCP in 
these two tissues (Durga Kumari, 1984). In a heterologous cell-free translation 
system, viz., rabbit reticulocyte lysate, a precursor RCP of Mr 38,000 is identified 
which is processed to native RCP in the presence of stripped microsomes from avian 
liver. The increased mRNA activity associated with chicken RCP production on 
secondary stimulation could be correlated with greater number of mRNA molecules 
due to enhanced transcription and/or due to stabilization of cytoplasmic RCP 
mRNA during secondary stimulation, as shown for vitellogenin, ovalbumin and 
conalbumm (Palmiter, 1972). 
Recent investigations have established that rodent RCP synthesis is also 
modulated by estrogen. Immunological studies have shown that a protein cross-re- 
acting with chicken RCP is detectable in the sera of ovariectomised female rats on 
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administration of estradiol- 17β (Muniyappa and Adiga, 1980). Moreover, the levels 
of the protein is clearly modulated by circulatory concentrations of estrogen during 
the 4-day estrous cycle: the concentration of the protein is highest during pro-estrous 
when estrogen concentration is the highest. The concentration of the protein appears 
to change during pregnancy with a gradual increase to peak around day 10 of 
gestation and is maintained more or less at high levels till term. These studies 
employed a heterologous RIA utilising [125I]-labelled chicken RCP and antiserum 
to chicken RCP. Using a homologous RIA for rat RCP, the hormonal induction of 
the protein has been investigated (Murty and Adiga, 1982b) and the data are 
essentially in agreement with the results reported earlier. It is noteworthy that the 
rodent protein is also induced specifically by estradiol-17ß in a dose-dependent 
manner and its synthesis is blocked by cycloheximide (Murty and Adiga, 1982b).
The circulatory concentrations of monkey and human RCPs are also modulated 
by physiological changes in estrogen concentration that occur during the menstrual 
cycle and pregnancy. Administration of estradiol- 17 β to immature male or female 
monkeys is able to enhance circulatory concentrations of monkey RCP (Adiga et al., 
1986; Visweswariah, 1986). These results clearly reveal that the evolutionary 
conservation of RCPs extends not only to structural and physicochemical properties 
but also to their estrogen- denpendent elaboration by the liver. This implies an 
important role for these proteins during gestation in primates, presumably analogous 
to that established in the avian and rodent models. Confirmatory evidence for this 
premise stems from recent observations in our laboratory that active immunisation 
of adult female bonnet monkeys with chicken RCP leads to early termination of 
pregnancy, provided that the antibody titres in circulation are high enough to 
neutralise endogenous protein (Adiga et al., 1986). These results lend credence to 
our working hypothesis that the immunological similarities between the RCPs is a 
reflection of the vitamin carrier performing a definite and important function in 
primate reproduction in terms of facilitating transplacental flavin transport from the 
maternal supply line to the developing fetus (figure 2). 
 
 
Figure 2. Schematic representation of mechanisms of induction and transplacental
transport of RCP in the pregnant rat. 
Biochemical and immunological aspects of riboflavin carrier protein 97
 
From the foregoing, it is clear that RCP is highly conserved throughout evolution 
from the aves to humans, not only in terms of similarities in gross structure, but also 
with regard to the hormonal modulation of its induction during the reproductive 
phase and its obligatory role as vitamin carrier from the maternal system to the 
developing oocyte/embryo. It is now well recognised that fixation of changes in 
protein sequence or structure depend on whether the changes will be compatible 
with the biochemical function of the protein and the degree of dispensability of the 
protein for the survival of the organism. The gross similarities among the RCPs 
throughout evolution therefore emphasise the vital role this protein has to play 
during reproduction. 
 
Immunological studies on RCP 
 
The similarities in the physicochemical properties of various RCPs extend to the 
extensive immunological cross-reactivity observed with polyclonal antisera to 
chicken RCP. A strong, although not perfect, quantitative correlation exists between 
amino acid sequence similarity and immunological resemblance. Thus, proteins 
which have a greater than 40% divergence in amino acid sequence, show no immuno- 
logical cross-reactivity (Arnheim, 1973; Wilson et al., 1977), and in general, the degree 
of cross-reactivity observed between two homologous globular proteins is directly 
related to the degree of resemblance between their amino acid sequences (Arnheim, 
1973; Wilson et al., 1977). Therefore, by implication, the immunological cross- 
reactivity observed amongst RCPs is highly suggestive of similarities in amino acid 
sequences. However, the cross-reactivities observed with whole polyclonal antisera 
are influenced by a number of variables, such as the relative and absolute concen- 
tration and affinities of the different determinant-specific antibodies which comprise 
the antisera as well as the inevitable variations in response to antigen by individual 
animals. Monoclonal antibodies (MAbs), however, can provide an immunological 
comparison of proteins on a determinant-by-determinant basis, since small changes 
in protein structure may produce large changes in immunological cross-reactivity. 
Certain MAbs have been known to discern even single amino acid changes in the 
sequences of two proteins (Harris, 1983) and hence, by virtue of their property of 
each reacting only with a single determinant, may provide exquisitely sensitive 
probes for discriminating between structurally related proteins. With this view in 
mind, we have raised MAbs to chicken RCP in an attempt to study more closely the 
homology in various determinants between RCPs of different species and in order to 
gain further insight into the antigenic map of chicken RCP and sequence divergence, 
if any, in the RCPs present in mammalian sera. 
Studies hitherto on the antigenicity and antigenic domains of chicken RCP are few 
and more detailed analysis is needed. The protein is highly antigenic and antibodies 
can be raised in a variety of mammalian species, viz., rabbit, rat and monkey (Cotner, 
1972; Ramanathan et al., 1979). Chemical modifications of RCP reveal that the 
protein moiety largely contributes to the antigenicity of the protein (Ramanathan 
et al., 1980). Total reduction of the disulphides, NBS-oxidation of the tryptophans 
and succinylation or dinitrophenylation of the lysine residues results in a loss of 
flavin binding capacity as well as antigenicity (Ramanathan et al., 1980). Deglyco- 
sylation apparently does not alter the antigenicity of the protein in a significant way 
(Ramanathan et al., 1980). Further investigation clearly shows that modification of 
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lysine residues affects the antigenicity drastically . Thus, a dinitrophenyl derivative of 
the holoprotein shows some antigenic similarity with the native protein, while DNP- 
apoprotein fails to give a similar reaction. Amidation of 88% of the lysines in the 
apoprotein is accompanied by 82% decrease in potential antigenicity with complete 
retention of flavin binding activity, but the slope of the inhibition curve of the 
amidiated derivative in RIA is different from that of the unmodified RCP indicating a 
weakening of almost all antigenic determinants (Cotner, 1972; Ramanathan et al., 
1980). Modifications of tryptophan and tyrosine residus in the protein do not alter 
its antigenic properties, but leads to a complete loss of flavin binding properties 
(Ramanathan et al., 1980). These observations lead to the inevitable conclusion that 
antigenic sites on the molecule are mostly localized in areas different from the ribo- 
flavin binding site. Moreover, holoflavoprotein and apoflavoprotein react similarly 
in RIA and Ouchterlony immunodiffusion analysis; the apoprotein bound to its 
antibody on an affinity column still interacts with flavin at 97% of the theoretical 
amount. The absence of any cross- reacting peptides in the trypsin hydrolysate of the 
citraconylated, totally reduced and alkylated apoprotein suggests that the antigenic 
determinants depend on secondary and/or tertiary structure (Murthy and Adiga, 
1978a). Lysine residues may be involved either at the actual antigeneic sites and/or 
their modification leads to drastic changes in the conformation of the protein. 
Lysine residues of globular proteins are mainly found localized on the surface of 
the molecule and protrude into the solvent rather than react with other residues 
(Arnheim, 1973; Wilson et al., 1977). There are several cases reported where the 
biologically active site is independent of the antigenic site and this is in agreement 
with the much studied phenomenon of the conservation of the active site of many 
enzymes through various stages of polygenetic development (Arnheim, 1973; 
Wilson et al; 1977). It is attractive to raise the question at this stage wheather various 
RCPs have retained an identical amino acid sequence/tertiary structure at the 
riboflavin binding region during evolution. With a view to study in greater detail the 
immunological cross-reactivity amongst avian and mammalian RCPs by a sensitive 
determinant-by-determinant approach, we have generated MAbs to chicken RCP by 
employing the hybridoma technique developed by Kohler and Milstein (1975). We 
have used the myeloma SP2/0-Ag as the fusing partner of mouse splenocytes and 
optimised immunisition protocols. Mice were immunised with chicken egg white 
RCP (Visweswariah, 1986). Fusion was performed with 50% polythylene glycol 
(PEG 4,500) and 10% dimethyl sulphoxide and the hybrid clones were screened by 
enzyme linked immunosorbent assay and a solid phase protein. A binding assay 
(Visweswariah et al., 1987). Three MAbs have been extensively characterised and 
their properties have been described recently (Visweswariah et al., 1987). The affinity 
calculated by Scatchard analysis for the parent antigen varies as expected with each 
antibody. These antibodies do not appear to differentiate between holo-and apo- 
RCP, in agreement with observations with polyclonal antisera. Denaturation of RCP 
with SDS also does not modify the interaction of the protein with these MAbs, but 
earlier results from this laboratory have shown that chicken RCP treated with SDS 
has significantly reduced affinity for riboflavin (Murthy, 1977). This is consistent with 
the premise that the flavin binding site is distinct from the major antigeneic 
determinants recognised by the 3 MAbs. However, as shown recently(Visweswariah 
et al., 1987), total denaturation of RCP by reduction and carboxymethylation 
eliminates recognition of the modified protein by the MAbs. This shows that none 
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of these MAbs recognize a linear sequence of amino acids per se and that at least a 
partially native conformation of chicken RCP is essential for interaction with these 
antibodies. Interestingly, succinylated chicken RCP is also not able to inhibit the
bindingof [125I]-labelled native chicken RCP to these MAbs even at a 100–fold
excess concentration, indicating that lysine residues are involved in the recognition of 
the protein by these antibodies, in agreement with the observations made with 
polyclonal antisera. 
Using a novel method of epitope analysis using Superose 12 gel filtration in 
conjunction with fast protein liquid chromatography, it could be shown that the 3 
MAbs are directed to 3 different and distinct epitopes on the chicken RCP molecule 
(Karande et al., 1987). Employing these MAbs, studies were initiated to ascertain 
whether the epitopes on chicken RCP to which these MAbs are directed are 
conserved in mammalian RCPs. As expected we could indeed observe an inhibition 
of binding of [125I]-labelled chicken RCP to each of these MAbs by different 
concentrations of rat, monkey and human RCPs (Visweswariah et al., 1987). This 
indicates that the epitopes defined by these MAbs are clearly present in mammalian 
RCPs as well. By employing RCP isolated from human pregnancy serum and 
umbilical cord serum, we could show that at least in the regions defined by the 
3 MAbs, the two proteins were nearly identical, as gauged by very similar affinities of 
the MAbs for them (Visweswariah, 1986). If one assumes that the protein from cord 
serum is largely of fetal liver origin, then there is apparently no significant difference 
between the embryonic and the adult RCP gene products at least in terms of these 
epitopes. The results obtained using MAbs are in close agreement with our earlier 
observations employing polyclonal antisera and provide a means of mapping the 
various epitopes on the chicken RCP molecule. 
Towards this end, a number of other MAbs to chicken RCP have been produced 
and are being characterised at present (Kuzhandhaivelu, N., Karande, A. A. and 
Adiga P. R., unpublished results). Preliminary results indicate that one of the MAbs 
is able to recognise egg white RCP but not egg yolk RCP. As stated earlier, the 
difference between these isoproteins is the two carbohydrate chains and the 13 amino 
acid chain at the C-terminus which is present in egg white and serum RCP but is 
cleaved off during uptake by oocytes to produce mature yolk RCP (Norioka et al., 
1985). It is therefore likely that one of the MAbs recognises the conformation 
associated with these 13 amino acids, and this region could represent a continuous 
epitope on the chicken RCP molecule (Sela, 1969). Alternatively, this ΜAb could 
recognise one of the carbohydrate chains exclusive to the egg white. We also have 
preliminary evidence to show that one of the other MAbs recognizes in solid-phase 
RIA the phosphopeptide isolated from egg white RCP representing the sequence of 
amino acids from 181-204 (figure 1). 
An attempt has been made to theoretically predict the possible antigenic domains 
on the chicken RCP molecule by performing a hydrophilic analysis (Hopp and 
Woods, 1981; Visweswariah, 1986) using the known amino acid sequence of chicken 
RCP (Norioka et al., 1985). This exercise was prompted by the recent evidence that 
antigenic domains on globular proteins are localised on the surface of the protein 
molecule in regions of high atomic mobility (Tainer et al., 1985) and as a 
consequence, hydrophilic regions of the protein are most likely to be antigenic as 
they are found predominantly on the surface of the molecule (Benjamin et al., 1984). 
The results of the hydrophilic analysis are shown in figure 3. The region of highest 
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Figure 3. Hydrophilicity profile of chicken RCP. The hatched line indicates the profile 
obtained when asparagine is present in the sequence at position 14 instead of lysine. The 
averaged hydrophilicity values are plotted versus position along the amino acid sequence. 
The x-axis contains 214 increments, each representing an amino acid in the sequence of 
chicken RCP. The y-axis represents the range of hydrophilicity values from – 3 to + 3. The 
data points are plotted at the centre of the averaging group from which they were derived. 
 
 
hydrophilicity is in sequence (108–118) and this is likely to be an antigenic domain. It 
appears that there are 3 major hydrophilic regions in the molecule (60–70, 105–115, 
120–140) and it is attractive to propose that the MAbs described here are directed to 
these 3 regions. 
This theoretical excercise may be able to predict with a certain degree of 
confidence some sequences which comprise antigenic domains of the protein. 
However, the smaller hydrophilic peaks are not always associated with immunogenic 
sites (Hopp and Woods, 1981). An improved method which eliminates to a great 
extent the redundancy of prediction makes use of the recognition factors of various 
amino acids (Fraga, 1982) and this correction has been applied to the analysis of 
chicken RCP (figure 4). Each amino acid in the chicken RCP primary sequence is 
assigned a recognition value and these values are repeatedly averaged over 6 
residues. Figure 4 indicates the recognition value of the residue at the mid-point of 
each hexa-peptide. The assumption that regions of high hydrophilicity and low 
recognition are antigenic may lead to accurate prediction of antigenic domains with 
a high success rate. It can be seen that some regions of highest hydrophilicity in 
chicken RCP have a very low recognition value and therefore are most likely to be 
contained within antigenic determinants. Based on a similar consideration, the 
region (120–140) is also likely to comprise a determinant. However, other minor 
peaks of hydrophilicity appear to be non-immunogenic in that they coincide with 
peaks in the recognition profile. The region of the phosphopeptide (182–204) perhaps 
is of greatest interest, since a definite biological activity has been assigned to it 
recently (Miller et al., 1982b). This sequence is contained within a region of high 
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Figure 4. Recognition profile of chicken RCP. Recognition values were assigned to each 
residue in chicken RCP and repeatedly averaged over each hexapeptide. These averaged 
values are plotted versus position along the amino acid sequence. The y-axis represents the 
range of recognition values, and the data points are plotted at the centre of the averaging 
groups from which they were derived. The hatched line indicates the values obtained when 
asparagine is present in the sequence at position 14 instead of lysine. 
 
 
recognition and is normally unlikely to be within an antigenic domain. However, in 
all these analysis, no correction is made for amino acid residues modified by 
phosphorylation or glycosylation and it is quite likely that these may cause shifts in 
both hydrophilicity and recognition value. The high charge of the phosphate in 
chicken RCP could induce certain changes in the structure of the protein such that 
the phosphopeptide is exposed to the surface. Isolation of the phosphopeptide and a 
study of its immunogenicity will provide information on whether this region is 
contained within an immunodominant site or not. 
The hydrophilic analysis in conjuction with the recognition profile of chicken RCP 
could thus provide information on the possible peptide sequences to which the 
MAbs to chicken RCP are directed. The analysis also explains certain conclusions 
reached from experiments conducted with polyclonal antisera. Firstly, there are 
reports that there is no difference in the polyclonal response to chicken apo-RCP 
and vitamin bound-RCP (Cotner, 1972; Ramanathan et al., 1979, 1980), despite the 
significant conformational changes that occur on binding of the vitamin at the active 
site. If tryptophan is critically involved in the binding of riboflavin to chicken RCP 
(Blankenhorn, 1978), and since it appears that 5 out of 6 of the tryptophan residues 
in chicken RCP are contained in hydrophobic pockets of the molecule (residues 54, 
84, 106, 120, 156) (figure 3), these residues may not be exposed to the surface of the 
molecule and could thus account for the non-immunogenicity of the riboflavin 
binding site. Another observation made using polyclonal antisera, is that there is no 
difference in antigenicity of egg yolk RCP and egg white RCP (Cotner, 1972). Egg 
yolk RCP differs from egg white RCP only in lacking 13 residues from residue 209 
onwards, and it is therefore possible that these residues are not dominant antigenic 
sites in the protein, despite their relative hydrophilicity and low recognition values. 
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Future prospects 
 
We are currently characterising a number of other MAbs and attempting to delineate 
the regions of their interaction with the chicken RCP molecule. By treating the 
native protein with trypsin or cyanogen bromide (CNBr), a number of peptides are 
produced some of which are recognized by a few MAbs (Kuzhandhaivelu, N., 
Karande, A. A. and Adiga, P. R., unpublished results). Sequencing of these peptides 
should indicate the exact regions on the chicken RCP molecule which interact with 
the antibodies. Hopefully, a few of the peptides generated from the chicken RCP 
molecule could be used as immunogens to generate antibodies which might cross- 
react with the native protein. A particularly attractive candidate for this could be the 
phosphopeptide which has been shown to be involved in uptake of chicken RCP by 
the oocyte. It is attractive to speculate that antibodies to this peptide could inhibit 
the binding of the native protein to the putative placental receptor thereby resulting 
in reduced uptake of the vitamin by the fetoplacental unit in pregnant mammals. 
Consequent to a complete understanding of the antigenic structure of chicken 
RCP, the MAbs could be used to probe further into the regions of homology in the 
mammalian proteins. The ability of MAbs to detect a single amino acid change in 
protein sequence should enable detection of the evolutionary conservation and diver- 
gence in the sequences of mammalian RCPs. Preliminary observations do indeed 
indicate that certain epitopes on mammalian RCPs are less conserved than others 
(Visweswariah, 1986). To confirm these observations, the cloning of chicken RCP 
cDNA is in progress. Cloning of the chicken RCP gene from a chicken liver cDNA 
library, followed by sequencing of the gene and hybridisation studies with rat and 
human genomic libraries should again substantiate the prediction regarding the 
extensive evolutionary conservation of the carrier protein. A few examples of 
proteins that have been conserved to a high degree are known. RCP joins this list 
because it is a protein whose physicochemical, immunological, functional and 
biosynthetic characteristics appear to remain grossly unchanged during the tran- 
sition from oviparity to viviparity. 
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